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The molecular mechanism underlying the extinction of lipoprotein lipase (LPL) expression in rat liver during development was investigated. A mouse 
(BWTG3) and a rat (7777) hepatoma, both of which exhibit characteristics of fetal hepatocytes, were found to contain LPL mRNA, whereas the 
more differentiated human (Hep G2 and Hep 3B) or rat (Fa32) hepatoma cell lines did not. Somatic cell hybrids between LPL-producing hepatoma 
cells and non-LPL-producing cells, such as adult rat hepatocytes or fibroblasts, exhibited extinction of LPL gene expression. Assay of expression 
of nested deletions in the 5’ regulatory sequences of the LPL gene in the Hep G2 ceil line and in BWTG3 cells localized sequences involved in the 
suppression of LPL production to a region between -591 and -288 relative to the transcription initiation site. A site with sequence homology to 
a glucocorticoid responsive lement (GRE) was shown not to play an important role in the extinction process. A novel transcription factor, termed 
RF-I-LPL, was shown to bind to an NF-l-like site in this region. In contrast to neonatal animals, in adult animals an additional protein complex 
(RF-2-LPL), was formed on the NF-l-like site, suggesting that this sequence might recruit a trans-acting factor involved in the extinction of LPL 
gene expression in adult rat liver. 
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1. INTRODUCTION 
Lipoprotein lipase (LPL), which catalyzes the hydrol- 
ysis of triacylglycerols of lipoprotein particles, is a se- 
creted enzyme with a relative molecular mass of 57,000 
and functions as a homodimer in vivo (reviewed in [l]). 
After secretion LPL becomes bound to glycosaminogly- 
cans on the luminal surface of extrahepatic capillary 
endothelium, where it hydrolyzes core triglycerides in 
triglyceride-rich lipoproteins, such as chylomicrons and 
very low density lipoproteins (reviewed in [l]). The re- 
leased free fatty acids are either oxidized to generate 
ATP in muscle, stored in adipose tissue, or secreted in 
milk by the mammary gland. LPL therefore occupies a 
pivotal position in both lipoprotein and energy metabo- 
lism. LPL synthesis is induced during differentiation in 
a number of cell types and tissues including adipocytes, 
monocytes, skeletal and cardiac muscle (reviewed in 
[l]). Adult rat liver normally synthesizes hepatic lipase 
but not LPL, whereas in neonatal rat liver LPL mRNA 
and protein are produced [2,3]. During development the 
expression of LPL becomes, however, extinguished in 
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rat liver. The present study aims at investigating the 
molecular mechanisms involved in the extinction of ne- 
onatal rat liver LPL production. Hepatoma cell lines, 
which are still capable of producing LPL were identified 
and analysis of somatic cell hybrids obtained from fu- 
sion of such LPL-producing hepatoma cells with other 
non-LPL-producing cells suggests that suppression of 
LPL synthesis in adult liver cells involves a developmen- 
tally regulated specific trans-acting extinguisher. A re- 
gion in the 5’ upstream regulatory sequences (URS) of 
the LPL gene was shown to possibly mediate neonatal 
extinction of LPL gene transcription. In this region a 
NF-1 like sequence was identified, which forms differ- 
ent protein complexes with liver nuclear extracts from 
adult versus neonatal animals. It is speculated therefore 
that the extinction process of the LPL gene involves 
interaction of a nuclear protein with the NF-l-like site. 
2. EXPERIMENTAL 
2.1. Cell culture and transfections 
The human hepatoblastoma cell lines, Hep 3B and Hep-G2, the 
human epitheloid carcinoma cell line, HeLa, and the mouse tera- 
tocarcinoma cell line, F9, were obtained from the American Type 
Culture Collection. The mouse hepatoma cell line, BWTG3 [4], and 
the rat hepatoma cell lines, 7777 [5] and Fa32 [6,7], a derivative of the 
H4IIEC, line [S], were described previously. The BS 140 and BS 181 
pl0 cells are cell hybrids formed between malignant mouse hepatoma 
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(BWTG3) and normal rat skin fibroblasts [9]. The LB 2100 and LB 
2041 are cell hybrids between the mouse hepatoma line BWTG3 and 
adult rat hepatocytes were described previously [lo]. Each of the 
hybrids retained at least one copy ofeach rat chromosome ([lo,1 l] and 
unpublished data). Cells were maintained in Dulbecco’s modiied 
Eagle’s minimal essential medium (DMEM) supplemented with 10% 
fetal calf serum at 37°C in a humidified atmosphere of 5% C02, 95% 
air [12,13]. For the somatic cell hybrids the medium was supplemented 
with 100pM hypoxanthine, 4pM aminopterin, and 16flM thymidine. 
Hela, F9, BWTG3, and Hep-G2 cells were transfected at 60-70% 
confluency. A total of 5 pug of plasmid DNA was transfected by the 
calcium phosphate coprecipitation procedure (10 h contact time). 
After washing with PBS, fresh medium was added and cells were 
harvested after a 16 h incubation. Chloramphenicol acetyl transferase 
(CAT) activity was determined on cell extracts, after normalizing to 
B-galactosidase activity (derived from cotransfected /I-galactosidase 
plasmid), as described by Gorman et al. [14]. 
2.2. Recombinant plasmids 
pHLPL-26 contains a human LPL cDNA clone [12,15]; genomic 
restriction fragments containing various lenghts of the LPL 5’ up- 
stream sequences were subclones of clone B-l [15]. The LPL 5’ up- 
stream sequences were cloned into the polylinker of the promotor-less 
expression vector KS-O-CAT [16] and a scheme of these constructs 
can be seen in Fig. 2A. KS-PN-CAT contained a fragment spanning 
-1719 to +136, KS-XN-CAT a fragment from -852 to +136, KS- 
AN-CAT a fragment from -230 to + 136 of the LPL genomic sequence 
(- refers to 5’ upstream sequences as defined in [15]. Finer deletion 
mutants KS-XN-l-CAT (-827 to +136), KS-XN-2-CAT (-768 to 
+136), KS-XN-4-CAT (-591 to +136), and KS-XN-5-CAT (-288 
to +136) were used for detailed mapping. All constructs were exam- 
ined by restriction mapping and partial sequencing. KS-O-CAT was 
used as a negative control, while KS-SV40-CAT, containing the SV- 
40 promotor and a CMV-driven /J-galactosidase plasmid served as a 
positive control and a control for transfection efficiency, respectively. 
The GR-DBD prokaryotic expression vector was described by De Vos 
et al. [17,18]. 
2.3. Analysis of RNA 
RNA was isolated by the guanidine isothiocyanate method and 
analyzed either by electrophoresis through 1.2% agarose-formalde- 
hyde gels followed by capillary transfer to nylon membranes, or by dot 
blot hybridization as described [12]. Transcripts were quantitated by 
densitometric tracing of autoradiographs following hybridization to 
a r2P-labeled 1.36 kb EcoRI fragment of the human LPL cDNA clone 
(hLPL-26; specific activity of 1 x 10’ cpm/pg) [12]. A rat [19] or a 
human apo E [12], and a chicken /3-actin [20] clone were used as 
controls. 
2.4. Nuclear extracts and gel retardation assays 
Nuclear extracts from cell cultures and tissues were prepared exactly 
as described by Dignam et al. [21] and by Gorski et al. [22], respec- 
tively. Final protein concentrations were typically 24 mg/ml. Con- 
struction of the GR-DBD prokaryotic expression vector and produc- 
tion of GR-DBD fusion proteins with protein A (GRFl) was per- 
formed exactly as described by De Vos et al. [17,18]. DNA-protein 
binding assays were performed as follows in a 20 ~1 reaction mixture. 
Nuclear extracts (l-3 ~1) were incubated for 20 min at room temper- 
ature with 2 pg poly(dI:dC) and radiolabelled probe in TM buffer (25 
mM NaCl, 20 mM Tris-HCl pH 7.4, 1 mM MgCl2, 0.5 mM EDTA, 
5 mM DTT, 10% glycerol). DNA-protein binding, and subsequent 
separation of DNA-protein complexes on a 5% polyacrylamide gel 
were performed essentially as previously described [23-251. As probes 
to study the LPL-NF-l-like site a synthetic double-stranded 30 bp 
oligonucleotide (wild-type LPL; S’GATCCATCTTGCCAATGTT- 
AAAACACCAGA-3’) spanning from nucleotide -514 to -487 of the 
human LPL gene S’URS was used. Other oligonucleotides include 
LPL-ml (5’-GATCCATCTTGCCAATGTCGAAACACCAGA-3’) 
and LPL-m2 (S-GATCCATCTTGCGCA~TTAAAACACCAG- - 
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A-3’). For the delineation of the glucocorticoid response element 
(GRE) overlapping DNA fragments spanning the GRE were used 
initially (-665 to -419 and -522 to -227 and -144 to +17). Later a 
23 bp synthetic oligonucleotide containing the GRE was used as probe 
(5’-AGCTGGGACGCAATGTGTGTCCC-3’). In some control ex- 
periments a 21 bp oligonucleotide representing the third GC box of 
the SV-40 promotor was used. 
2.5. DNase I footprinting assays 
DNase I footprinting reactions were performed essentially as de- 
scribed by Jones et al. [26] using nuclear extracts isolated from rat 
livers (see above). In short, probes end-labelled on one strand were 
prepared by PCR amplification of plasmid DNA using one cold 
primer and one labelled primer. These labelled DNA fragments were 
incubated in a total volume of 50 ~1 containing 10 mM Tris-HCl pH 
7.9,50 mM KCI, 6.25 mM MgCl,, 0.05 mM EDTA, 1 mM DTT, 8.5% 
v/v glycerol, 2% polyvinylalcohol, and 1 pug poly(dI:dC]) with l&20 
pg nuclear extract. After incubation for 20 min at room temperature, 
50 ~1 of 5 mM CaCl,, 20 mM MgCl, was added, then 4 ~1 of freshly 
prepared DNase I diluted in 50 mM MgCl, was added. Digestion was 
allowed for 60 s at room temperature, after which 100 ~1 stop buffer 
(20 mM EDTA, 200 mM NaCl, 1% w/v SDS) was added. Reactions 
were analyzed on 8% polyacrylamide/8 M urea sequencing els after 
extraction with phenol chloroform and isopropanol precipitation. 
3. RESULTS AND DISCUSSION 
3.1. LPL expression in hepatoma cell lines 
LPL mRNA is, like a-fetoprotein (AFP), expressed 
in fetal but not in adult liver [3,27]. Indeed, shortly after 
birth, liver LPL gene expression is extinguished. It was 
shown that hepatoma cell lines that exhibit adult char- 
acteristics, though they also produce AFP, such as the 
two human cell lines Hep G2 and Hep 3B do not pro- 
duce any detectable LPL mRNA, whereas the mouse 
fetal hepatoma line BWTG3 (producing AFP) ex- 
pressed substantial amounts of LPL mRNA (Fig. 1; see 
also [28]). In the present study these analysis were ex- 
tended to two rat cell lines. In fact, rat Fa32 hepatoma 
cells, which display adult characteristics and does not 
produce AFP, lack LPL mRNA, whereas the less differ- 
entiated 7777 cell line (which produces AFP) still pro- 
duces LPL mRNA (data not shown). The production 
of LPL by hepatoma cell lines expressing fetal traits is 
consistant with hepatocytes being the source of LPL in 
the neonatal liver, and thus uch cell lines are a useful 
in vitro model systems to study the control of liver LPL 
gene expression. These data support the notion that 
LPL production is a fetal hepatocyte trait. LPL would 
thus belong to a class of hepatic proteins which like 
AFP are expressed uring fetal hepatic tissue differenti- 
ation and are repressed once full tissue maturation is 
reached [29-311; however, a strict correlation between 
LPL and AFP expression is not observed since some 
hepatoma cells (Hep G2, Hep 3B) only express AFP. 
3.2. LPL mRNA is extinguished in hybrids between 
LPL-producing and non-producing cells 
Although we had previously shown that the produc- 
tion of LPL in rat liver could be modified in vivo by 
treatment with either glucocorticoid or thyroid 
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Fig. 1. LPL mRNA in hepatoma cell lines (lanes 1 and 2) and in cell 
hybrids (lanes 3-5). Twenty pg of total RNA was analysed by North- 
em blot hybridization. Mouse LPL mRNA, which represents asingle 
species, is indicated by an arrowhead; Lane 1, adult rat liver RNA; 
lane 2, BWTG3 RNA; lane 3, rat skin fibroblast RNA; lane 4, BS140 
RNA; lane 5, LB 2100 RNA. Description of the hybrids can be found 
in section 2. 
hormone [3], several observations suggest that factors 
other than these hormones might be involved in the 
neonatal extinction process. First, prolonged hypothy- 
roidism in the adult rat did not restore liver LPL pro- 
duction (Staels and Auwerx, unpublished data). Sec- 
ond, glucocorticoid hormone did not influence LPL 
production in BWTG3 cells [28]. Although the absence 
of a response of the LPL gene to glucocorticoids in 
BWTG3 cells could be due to the absence of a receptor, 
the activation of an LTR-CAT construct by addition of 
dexamethasone to BWTG3 culture medium ([28] and 
not shown) argues against this last possibility. The 
availability of hepatoma cell lines, expressing LPL, 
however, provided a good tool to study the molecular 
mechanism of this extinction. Data obtained from stud- 
ies of cell hybrids derived from the fusion of LPL-pro- 
ducing mouse hepatoma cell line, BWTG3, with non- 
LPL-producing rat cells argued strongly against hormo- 
nal factors being the sole cause of extinction. In fact two 
different types of hybrids were tested for the presence 
of LPL mRNA (Fig. 1): hybrids derived from the fusion 
of the BWTG3 with cells of a non-hepatic lineage, such 
as rat fibroblasts, or hybrids derived from the fusion of 
BWTG3 with hepatic cells at a different stage of devel- 
opment, such as adult rat hepatocytes. BWTG3 x rat 
skin fibroblasts hybrids, (BS 140 and BS 181plO), both 
of which have retained at least one copy of each rat 
chromosome [111, contained no detectable LPL mRNA, 
arguing for an extinction of LPL gene expression by a 
factor provided by the rat fibroblast genome (Fig. 1). 
Two hybrid lines derived from the fusion of BWTG3 
with adult rat hepatocytes (LB 2100 and LB 2181; lo), 
were also analyzed for LPL mRNA production (Fig. 1). 
LPL gene expression was likewise extinguished in these 
two hybrid lines, which also retained at least one copy 
of each mouse and rat chromosome. LPL expression 
thus appears to be extinguished not only in hybrids 
formed between cells of different histiotypes (BWTG3 
hepatoma cells x fibroblasts) but also in hybrids 
formed between cells of the same lineage but at different 
developmental stages (BWTG3 hepatoma cells x adult 
hepatocytes). This situation is in contrast with that of 
the AFP gene, which is not extinguished in BWTG3 x 
hepatocyte hybrids [lo]. Since glucocorticoid or thyroid 
hormones negatively modulate expression of LPL in 
vivo [3], it is conceivable that LPL extinction in these 
hybrids could be caused by the presence of hormones 
in the tissue culture medium. This hypothesis seems, 
however, unlikely, since similar results (absence of LPL 
mRNA) were obtained when these hybrid cells were 
grown in medium from which these hormones were re- 
moved by adsorption with charcoal. 
By using similar somatic cell and microcell hybrid 
studies it has been shown previously that the tissue- 
specific extinction of several genes is mediated in cis by 
specific loci, which also implicates trans-acting factors 
in this process [32,33]. Examples of such tissue specific 
extinction include the genes for a-fetoprotein [7,34,35], 
tyrosine aminotransferase [33,36,37], the T cell antigen 
receptor [38] or albumin [7,32,39]. The LPL gene might 
therefore be another example of a gene regulated by 
extinguisher factors produced by non-LPL-expressing 
cells. 
3.3. Localization of DNA sequences responsible for 
extinction 
The existence of &-acting regulatory sequences 
within the 5’ upstream region of the LPL gene that 
could respond to the trans-acting extinguisher was next 
explored. Expression vectors, in which nested deletions 
of the 5’ LPL regulatory sequences (Fig. 2A; [15]) were 
used to drive the expression of the reporter gene CAT, 
were transiently transfected into Hep G2 and BWTG3 
cells (Fig. 2B). The deletion of a region between -852 
and -230 (relative to the major transcription initiation 
site described by Deeb and Peng [15] resulted in the 
consistent expression of the 5’-LPL-CAT reporter gene 
in the non-LPL-expressing Hep G2 cells (KS-AN- 
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Fig. 2. Localization of extinguisher-responsive sequences in the LPL gene. (A) Structure of some of the reporter constructs used in the transient 
transfection experiments. Genomic restriction fragments containing various lengths of the LPL 5’ upstream sequences were cloned into the 
polylinker of the vector KS-SVO-CAT as described. (B) Representative transfection experiment in either BWTG3 or Hep G2 cells localizing the 
extinguisher-responsive element to a region between -852 and -230 of the LPL 5’ end. Ten pug of each plasmid (depicted in panel A) was 
cotransfected with 5 pg of CMV;B-galactosidase and CAT activity determined as described 
CAT; Fig. 2B and Table I). In addition, deletion of the 
same region (between -852 and -230; KS-AN-CAT) 
allowed the expression of LPL-CAT hybrid genes in 
different non-LPL-producing cell lines, such as HeLa 
cells or F9, mouse teratocarcinoma cells (data not 
shown). Deletion of this sequence had no major influ- 
ence on the expression of S-LPL-CAT constructs in the 
LPL-expressing neonatal BWTG3 cells (Fig. 2B & 
Table I). Transfection with constructs containing small 
deletions defined the region important for extinction to 
a region between -591 and -288 (Table I). These results 
indicate that, as in other systems previously described, 
extinction could occur by interaction of extinguisher 
proteins with specific DNA motifs (-591 to -288) in the 
promoter-enhancer egion of the gene. 
3.4. IdentiJication of transcription factor binding site to 
the 5’URS of LPL implicated in extinction 
By homology searches we could identify 4 potentially 
important regulatory elements in the region between 
-591 and -288 (Fig. 3) i.e. a potential GRE (GG- 
GACGCAATGTGTG at -468/-455) [40], an NF-1 
like site (CCATC’ITGCCAATGTIAAAACACCAGA 
at -514/-487) [41-43], and one HNF-3 binding site 
(CATTGACTTTG at -440/-430)[44]. It is important 
to note that none of these sites except for the NF-1 like 
site was protected by DNase I footprinting techniques 
using up to 40 ,ug of liver nuclear extracts (data not 
shown). The absence of a footprint on the HNF-3 site 
made it highly unlikely that the liver-enriched factor, 
HNF-3 was important in the regulation of this extinc- 
tion process. Due to the low abundance of steroid recep- 
tors in nuclear extracts, steroid response elements are 
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only rarely protected in DNase I footprinting assays 
using nuclear extracts. Therefore, we investigated 
whether this GRE could be delineated by electro- 
phoretic mobility shift assay (EMSA) utilizing a bacteri- 
ally synthesized recombinant protein composed of the 
DNA-binding domain of the glucocorticoid receptor. 
By using overlapping DNA sequences of the LPL 
SURS, we could map the GRE to the region between 
-468/-455 (Fig. 3). The presence of a glucocorticoid 
receptor binding site was confirmed by using a short 
double stranded oligonucleotide, representing strictly 
Table I 
Expression of deletion mutants of the LPL 5’URS in different 
hepatoma cell lines (Hep G2 and BWTG3; section A) and after treat- 
ment with glucocorticoid hormones (in BWTG3 cells either in the 
presence or absence of 10 ,uM dexamethasone; section B). 
A. Hep G2 BWTG3 
KS+-AN-CAT 830 f 61 (4) 143 ?: 15 (4) 
KS+-XNS-CAT 739 + 72 (3) 105 + 20 (3) 
KS+-XN4CAT 79 + 10 (3) 126 + 8 (3) 
KS+-XN2CAT 71 f 16 (3) 91 f 9 (3) 
KS+-XN-CAT 88 * 10 (4) 120 f 11 (4) 
KS+-PN-CAT 100 (4) 100 (4) 
B. - Dexamethasone + Dexamethasone 
KS+-XN-CAT 92 f 12 (3) 110 f 18 (3) 
KS+-PN-CAT 100 (3) 8.5 + 7 (3) 
Values represent mean + SD. of several transfection experiments (the 
number in brackets indicates the number of independent experiments). 
Numbers were corrected for transfection efficiency and weighed 
against the expression of KS-PN-CAT in unstimulated cells (which 
was set arbitrarily at 100). 
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Fig. 3. Identification of a binding site of the GRE to the LPL 5’ region. (A) Gelshift (EMSA) assay showing the binding of the DNA binding domain 
of the glucocorticoid receptor to the LPL 5’ URS. Lanes 1,3,5: no extract added (/); lanes 2,4,6: GRF- 1, the glucocorticoid receptor DNA binding 
domain fusion protein with protein A (G) . Labelled DNA fragments used as probes (probes A and B) in lanes 14 are depicted in the figure in 
panel B. In lane 5 and 6 a radiolabelled 23 bp oligonucleotide representing only the GRE was used as probe. Gelshift assays were performed exactly 
as described in section 2. (B) Graphic representation of a part of the S’URS of the LPL gene. The potential responsive lements, as well as the 
probes used in panel A, are indicated. The DNA fragments used as probes are highlighted above the figure. 
the LPL-GRE (Fig. 3). Although these data demon- 
strated the presence of a GRE, its functional signifi- 
cance in liver cells was unclear. LPL gene expression in 
BWTG3 cells was not affected by glucocorticoid 
hormones, despite the presence of a functional gluco- 
corticoid receptor [28]. Furthermore, cotransfection of 
a glucocorticoid receptor expression vector (either in 
the presence or absence of dexamethasone in the culture 
medium) with the KS-XN-CAT reporter construct had 
no effect on CAT expression in LPL expressing 
BWTG3 hepatoma cells (Table I). The NF-l-like site 
was therefore further tested for its possible role in the 
extinction process. 
3.5. A novelfactor RFl-LPL binds to an LPL-NF-l-like 
site in the -591/-288region 
Utilizing DNase I footprinting, this NF-l-like site, 
which showed strong sequence homology to a typical 
CCAAT box [4143], was in fact the only site protected 
by employing liver nuclear extracts from either neonatal 
or adult animals (Fig. 4A). It was interesting to note 
that the extent of protection was consistently greater 
when liver extracts of adult animals were used relative 
to extracts from neonatal animals. In addition, when 
higher amounts of nuclear extracts were used an exten- 
sion of the footprint became evident in extract from 
adult rats (Fig. 4A; compare lane 7 to lane 8). This 
extention was more pronounced with extracts from 
adult animals when compared to neonatal animals. 
Since this NF- 1 -like site is a potentially important previ- 
ously undescribed cis-acting element, we set out to 
analyse the proteins that interacted with it in more de- 
tail by EMSA (Fig. 4B). Upon incubation of a double- 
stranded oligonucleotide, encompassing the sequence 
protected by DNase I footprinting analysis, with liver 
nuclear extracts of neonatal animals, a specific protein- 
DNA complex could be observed. In contrast, when 
liver nuclear extracts from adult animals were used a 
second complex of slower mobility could be visualized 
in addition to the complex present in neonatal animals. 
Both of these complexes were competed by a 30-fold 
molar excess of unlabelled wild-type LPL oligonucleo- 
tide. It was interesting to note that LPL-m2 oligonucle- 
otide, in which the CCAAT box itself was mutated com- 
peted as efficiently as the wild-type LPL oligonucleo- 
tide, suggesting that the CCAAT sequence was not very 
important in the binding of this factor. In contrast com- 
petition experiments with a 30-fold excess of LPL-ml 
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Fig. 4. An additional factor binds to the LPL-NF-1 site in adult vs. neonatal animals. (A) DNase I footprint experiment. The footprint (indicated 
by the shaded bar) was consistently stronger, when equivalent amounts of neonatal (N) and adult (A) extracts were compared. Several hypersensitive 
sites are evident and are indicated by an asterisk (*). G depicts a G sequence reaction and I represents the degradation pattern when no nuclear 
extracts were added. When 40 pg of liver extract was used an extension of the footprint became vident owards both 3’ and S’ ends (see arrows). 
(B) Sequence of the footprinted region. (C) Gel shift experiment showing an additional complex present in adult animals. Unlabelled oligonucleotide 
representing either the LPL NF-l-like site or 2 mutations (LPL-ml and LPL-m2) of this site were used in the competition experiments. (D) 
Oligonucleotid~ used in the competition experiments. The palindromic sequence isindicated by arrows. Mutated base pairs in LPL-ml and LPL-m2 
are ~derlined. 
oligonucleotide containing a Z-bp substitution in an- 
other region of the protected site, resulted in a loss of 
competition. 
These data suggest that this additional factor binding 
to this LPL-NF-1 site (present in adult animals only), 
might be a transacting factor or extinguisher implicated 
in the extinction or negative regulation of LPL gene 
expression. At present he factors binding to this site in 
neonatal, as well as in adult animals are being charac- 
terized in more detail in the laboratory. It is not ex- 
cluded that this factor might interact with the GRE 
lying in close proximity, thereby controlling the extinc- 
tion process. 
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